← SynDRA
CIPEMASTAT
SynDRA canonical compound SYN0004207 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | ADAM17 | MMP1 | MMP13 | MMP2 | MMP3 | MMP8 | MMP9 |
| Mechanism of action | metalloproteinase inhibitor |
All known targets
- MMP1
- MMP8
- ADAM17
- MMP13
- MMP2
- MMP3
- MMP9
Mechanisms of action (all sources)
- metalloproteinase inhibitor
- MMP8 MODULATOR
- MMP1 MODULATOR
Cross-references
Synonyms
- RO-32-3555/000
- RO-32-03555
- RO-323555000
- Trocade
- Ro 32-3555
- UNII-02HQ4TYQ60
- 02HQ4TYQ60
- GFUITADOEPNRML-SJORKVTESA-N
- Cipemastat [USAN:INN]
- Ro 32-3555/000
- Trocade (TN)
- Cipemastat (USAN/INN)
- GTPL6466
- CHEMBL115653
- SCHEMBL7088217
- CTK8F1312
- BDBM30344
- MolPort-023-276-601
- ZINC600699
- (alphaR,betaR)-beta-(Cyclopentylmethyl)-gamma-oxo-alpha-((3,4,4-piperidinebutyrohydroxamic acid
- AKOS024457333
- HY-19677
- Ro-32-03555
- Ro-323555000
- RT-015421
- RO32-3555
- CS-0016192
- D03517
- J-012306
- cipemastatum
- RefChem:1100558
- DTXCID001326916
- C22H36N4O5
- CIPEMASTAT [INN]
- CIPEMASTAT [USAN]
- CIPEMASTAT [WHO-DD]
- orb1710047
- GLXC-01794
Look up CIPEMASTAT in the interactive SynDRA portal →